Atlas Trials

Evaluation of Safety, Pharmacokinetics, Distribution,Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRM

Clinical trial NCT07768306 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07768306
Sponsor
Norroy Bioscience Co., LTD
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Clear Cell Renal Cell Carcinoma (ccRCC)
Start date
2026-09-01
Primary completion
2027-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.